Synapse Medicine raised €25M in a Series B round in Mar 2022. The company is based in Bordeaux, France. Investors in the round: BNP Paribas Development, Fleur Pellerin investment fund, Korelya Capital and 2 others. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €25M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
